Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 35

Results For "skin"

368 News Found

MediBuddy records a steep increase in dermatology consultation amongst youngsters
Startup | October 22, 2021

MediBuddy records a steep increase in dermatology consultation amongst youngsters

The platform has seen an overall growth of 84% in the number of people seeking consultations for skin-related issues


Gland Pharma PAT declines to Rs 302 crore QoQ in Q2FY22
News | October 22, 2021

Gland Pharma PAT declines to Rs 302 crore QoQ in Q2FY22

The company’s wide therapeutic portfolio helped to sustain growth despite changing market demand


FDA approves Cyltezo, the first interchangeable biosimilar to Humira
Drug Approval | October 20, 2021

FDA approves Cyltezo, the first interchangeable biosimilar to Humira

Second interchangeable biosimilar product approved by agency


Trivitron launches SpaceD radiation protection aprons
Medical Device | September 22, 2021

Trivitron launches SpaceD radiation protection aprons

These aprons utilise phase change materials that absorb, store and release heat for optimal thermal comfort


Lincoln Pharma plans to launch Cephalosporin product portfolio soon
Drug Approval | September 21, 2021

Lincoln Pharma plans to launch Cephalosporin product portfolio soon

Cephalosporin is a bactericidal, broad-spectrum, and P-lactam antibiotic originally derived from the fungus Acremonium, which is used to treat bacterial infections such as pneumonia, skin infections, ear infection, strep throat, staph infections, tonsillitis, bronchitis among others


Qardio’s remote patient cardiac monitoring service launched
Medical Device | September 20, 2021

Qardio’s remote patient cardiac monitoring service launched

It is the first-ever fully remote end-to-end Remote Patient Monitoring (RPM) service to include cardiac arrhythmia analysis in a single, intuitive platform


HUL funds study on Covid-19 vulnerability and vaccine efficiency
News | September 07, 2021

HUL funds study on Covid-19 vulnerability and vaccine efficiency

The study is being carried out by the platform VISION (Vaccine Immunology Studies – Indian Outbreak-response Network) which includes top public and private research institutes.


Brinton launches Hohner Health in India
Healthcare | September 06, 2021

Brinton launches Hohner Health in India

The focus is on wellness and personal care products


Omeza Collegen Matrix gets U.S. FDA approval
Biotech | September 03, 2021

Omeza Collegen Matrix gets U.S. FDA approval

This is Omeza’s first Rx product and the first drug/device combination matrix of its kind for chronic wound care


Positive results from Pfizer’s Phase 3 trail comparing efficacy of abrocitinib and dupilumab
Drug Approval | September 01, 2021

Positive results from Pfizer’s Phase 3 trail comparing efficacy of abrocitinib and dupilumab

JADE DARE trial met co-primary and key secondary endpoints and demonstrated a safety profile consistent with previous studies for moderate to severe atopic dermatitis